Neumora Therapeutics (NMRA) shares were up 8% in recent Monday trading after RBC Capital Markets upgraded the company's stock to outperform from sector perform and raised its price target to $7 from $4.
Trading volume stood at over 1.8 million, versus the daily average of about 1.5 million.
Price: 2.42, Change: +0.18, Percent Change: +8.04